You searched for "lesions"

2532 results found

Expensive Malware

Cryptolocker and similar ransomware There is a new breed of computer malware that is spreading rapidly. The first major manifestation of this new type is known as Cryptolocker. At present it’s a Windows only problem (all versions), but it’s likely...

Take this waltz

My last weekend on-call was the busiest I can remember for a very long time. We were just completely swamped with patients. The weather was not too good that Saturday and it felt like every second inhabitant of our ocean...

Risk with density of suppression

The authors wished to determine the current practice of assessing and interpreting the density of suppression with the Sbisa / Bagolini filter bar in the management of amblyopia in the UK and to estimate the incidence of intractable diplopia following...

Detection of antiranibizumab antibodies in exudative AMD

In this study the authors aimed to detect immune response to ranibizumab treatment in wet age-related macular degeneration (AMD). An ELISA was employed to quantify the anti-ranibizumab titre which was compared against the control anti-abciximab titre. Titres of anti-ranibizumab antibodies...

Pharmacopoeia of the Royal Infirmary of Edinburgh

The compact volume depicted in Figure 1 bears the simple title Pharmacopoeia. The book originally belonged to the author’s father, the late John King. A pharmacist by profession, John King maintained a keen interest in matters pertaining to pharmaceutical history....

Genetic profiling for personalised healthcare solutions in AMD – an update

Age-related macular degeneration (AMD) is a multifactorial condition influenced by genetics and lifestyle factors (Table 1). This article outlines several recent advances in AMD genetics, as well as evolving therapeutic concepts and established practical measures for the treatment and /...

Conference Report: RCOphth 2025

This year’s Royal College of Ophthalmologists Annual Congress in Liverpool brought together eyecare professionals from across the country and beyond for four days of thought-provoking content, collaborative discussion and exciting glimpses into the future of ophthalmology. The opening day was...

Well-presented scholarly research work will reduce chances of journal rebuttal

Submitting to an academic journal? Are you aware of the requirements and constraints of relevant copyright laws? Rod McNeil provides a guide for aspiring authors. Getting published in peer-reviewed academic and medical journals is not easy. But careful attention to...

Developing eye health services in Malawi: a personal reflection

Dr Chinsisi Namate reflects on her first two years as a consultant ophthalmologist at the eye unit at Zomba Central Hospital, and how she has already successfully expanded eyecare services for southeast Malawi. The Lions Sight First Eye Hospital in...

Treat-and-extend regimen in treatment of patients with type 3 neovascularisation

Type 3 neovascularisation, also known as retinal angiomatous proliferation is a distinct subtype of neovascular AMD characterised by intraretinal neovascularisation. This retrospective study included 17 eyes diagnosed with type 3 neovascularisation who were changed from pro-re-nata (PRN) based treatment regime...

Update: Non-infectious retinal vasculitis

This review article summarises the update on non-infectious retinal vasculitis (RV). It is primarily classified based on the type of retinal vessels involved and further sub-classified as occlusive or nonocclusive. Clinically it can occur as an isolated ocular entity or...

Happy hour

Welcome Eye News Aug/Sep 2023, your bi-monthly tonic for a much-needed happy hour. In the current climate of challenge across all fronts, there’s no better time to reach out for the professional equivalent of a cheery cup in the company...